A Study Comparing Effect Of Exenatide, Insulin Or Pioglitazone On Glycaemic Control And Bone Metabolism In Drug-naive Type 2 Diabetic Patients: A Two Center 24-Week Randomized Parallel-Group Trial

Trial Profile

A Study Comparing Effect Of Exenatide, Insulin Or Pioglitazone On Glycaemic Control And Bone Metabolism In Drug-naive Type 2 Diabetic Patients: A Two Center 24-Week Randomized Parallel-Group Trial

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Feb 2017

At a glance

  • Drugs Exenatide (Primary) ; Insulin neutral protamine lispro/insulin lispro (Primary) ; Pioglitazone (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 17 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top